Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Clinical Pathology|October 23, 2020
Evaluation of an enhanced pathological examination protocol for sentinel lymph nodes from patients with breast carcinomaCiara Murray, Asmaa Al Shehhi, Ciarán Ó'Riain, et al.
Virchows Archiv : an International Journal of Pathology|August 4, 2019
Assessing the impact of the 2018 American Society of Clinical Oncology/College of American Pathologists recommendations on human epidermal growth factor receptor 2 testing by fluorescence in situ hybridization in breast carcinomaCiara Murray, Louise Flanagan, Claire D'Arcy, et al.
Gynecologic Oncology|May 12, 2024
Correlating the KELIM (CA125 elimination rate constant K) score and the chemo-response score as predictors of chemosensitivity in patients with advanced ovarian carcinomaSabrina Piedimonte, Ciara Murray, Eshetu G Atenafu, et al.
BMJ Case Reports|February 5, 2021
First use of tofacitinib to treat an immune checkpoint inhibitor-induced arthritisKieran Murray, Achilleas Floudas, Ciara Murray, et al.
Biomedical Optics Express|July 5, 2021
Toward a quantitative method for estimating tumour-stroma ratio in breast cancer using polarized light microscopyJillian Sprenger, Ciara Murray, Jigar Lad, et al.
Idcases|January 26, 2026
Saved by My Specs: Incidental central retinal vein occlusion uncovering infective endocarditis - A case reportDaniel Broderick, Ciara Murray, Padraig McGettrick, et al.
International Journal of Surgical Pathology|November 10, 2016
Composite Blastoid Variant of Mantle Cell Lymphoma and Classical Hodgkin LymphomaCiara Murray, Fiona Quinn, Gyorgy Illyes, et al.
NPJ Breast Cancer|December 15, 2025
The role of circulating tumor cell-associated genes in the progression of estrogen receptor-positive breast cancerMartin Rotbauer, Melanie Dawe, Kevin C J Nixon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2021
Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancerAyaka Katayama, Islam M Miligy, Sho Shiino, et al.
British Journal of Cancer|March 25, 2021
Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2.0, HER2 copy number <4.0 signals/cell) casesEmad A Rakha, Islam M Miligy, Cecily M Quinn, et al.
Pageof 1